News from the BioRN Cluster

Home  >>  News from the BioRN Cluster

Fraunhofer IGB: Nose2Brain – Effizientere Therapie von Multipler Sklerose

On April 26, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Fraunhofer IGB: Nose2Brain – Effizientere Therapie von Multipler Sklerose

In einem von der EU geförderten Forschungsprojekt entwickelt ein internationales Konsortium in den kommenden Jahren eine neue Technologie für eine bessere Behandlung von Multipler Sklerose. Der innovative »Nose2Brain«-Ansatz sieht vor, einen speziellen Wirkstoff direkt über die Nase in das zentrale Nervensystem zu transportieren. Zu diesem Zweck arbeitet das Fraunhofer-Institut für…

Heidelberg University: Construction start of European Institute for Neuromorphic Computing

On April 21, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Heidelberg University: Construction start of European Institute for Neuromorphic Computing

Heidelberger Wissenschaftler im Human Brain Project erhalten neues Forschungsgebäude Die Heidelberger Wissenschaftler im europäischen Human Brain Project erhalten ein neues Forschungsgebäude. Der Neubau für das European Institute for Neuromorphic Computing (EINC) der Universität Heidelberg soll in rund zweijähriger Bauzeit auf dem Campus Im Neuenheimer Feld errichtet werden. Mit dem traditionellen…

DKFZ: Outstanding Research on Brain Tumors- medical scientist Dr. Matthias Osswald receives Hella-Bühler-Prize

On April 21, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für DKFZ: Outstanding Research on Brain Tumors- medical scientist Dr. Matthias Osswald receives Hella-Bühler-Prize

Der Heidelberger Mediziner Dr. Matthias Osswald erhält den mit 100.000 Euro dotierten Hella-Bühler-Preis Dr. Matthias Osswald (Quelle: uni-heidelberg.de) Der Heidelberger Mediziner Dr. Matthias Osswald erhält den mit 100.000 Euro dotierten Hella-Bühler-Preis 2016. Die Auszeichnung wendet sich an junge Forscher am Wissenschaftsstandort Heidelberg, die bereits durch herausragende wissenschaftliche Qualität in der…

DKFZ: European million grants for three DKFZ researchers

On April 12, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für DKFZ: European million grants for three DKFZ researchers

Three scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have each been awarded one of the prestigious European Research Council (ERC) Advanced Grants comprising €2 million. One of the grants goes to Hans-Reimer Rodewald, who has developed a barcode system that makes it possible to track the path…

EMBL/DKFZ/Hi-STEM: Human blood cells develop in a continuous process instead of a stepwise one

On April 12, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für EMBL/DKFZ/Hi-STEM: Human blood cells develop in a continuous process instead of a stepwise one

Scientists from the German Cancer Research Center (DKFZ), the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) and the European Molecular Biology Laboratory (EMBL) used a new combination of analysis methods to study in single cells how blood stem cells in the bone marrow differentiate into mature blood…

DKFZ/Heidelberg University Hospital: Peptide acts as mediator for learning

On April 11, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für DKFZ/Heidelberg University Hospital: Peptide acts as mediator for learning

In order to adapt to changes in the environment, the brain produces new nerve cells (neurons) even at adult age. These young neurons are crucial for memory formation and learning. Scientists from the German Cancer Research Center (DKFZ) and Heidelberg University Hospital have now discovered that a small peptide plays…

EMBL to open new site in Barcelona

On April 11, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für EMBL to open new site in Barcelona

Spanish government and EMBL sign agreement for new site dedicated to tissue biology and disease modelling. At a ceremony in Barcelona today, EMBL and the Spanish government, represented by the Ministry of Economy, Industry and Competitiveness (MINECO), signed an agreement for a new EMBL site to be hosted in the…

TU Kaiserslautern: Professor Johannes Herrmann ist neuer Präsident der Gesellschaft für Biochemie und Molekularbiologie

On April 10, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für TU Kaiserslautern: Professor Johannes Herrmann ist neuer Präsident der Gesellschaft für Biochemie und Molekularbiologie

Professor Johannes Herrmann von der TU Kaiserslautern ist neuer Präsident der Gesellschaft für Biochemie und Molekularbiologie (GBM). Er wurde auf der jährlichen Mitgliederversammlung Ende März für zwei Jahre gewählt. Die GBM ist die größte deutsche Fachgesellschaft der molekularen Biowissenschaften. Sie hat rund 5300 Mitglieder aus Universitäten, Forschungseinrichtungen, Industrie und weiteren…

Heidelberg University: 2 Researchers Receive ERC Advanced Grant

On April 10, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Heidelberg University: 2 Researchers Receive ERC Advanced Grant

The European Research Council (ERC) has awarded biochemist Prof. Dr Ed Hurt and molecular biologist Prof. Dr Bernd Bukau a highly endowed ERC Advanced Grant for outstanding research leaders in Europe. Both grants comprise around 2 Mio Euro funding. Prof. Bukau Prof. Bukau is director of the Centre for Molecular…

Innovationspreis der BioRegionen: Therapien gegen HIV & Netzhautdegeneration sowie Bio-LEDs

On April 10, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für Innovationspreis der BioRegionen: Therapien gegen HIV & Netzhautdegeneration sowie Bio-LEDs

Wiesbaden/Hannover, 5. April 2017 Der Arbeitskreis der deutschen BioRegionen verleiht auf den Deutschen Biotechnologietagen in Hannover zum zehnten Mal den Innovationspreis. Die drei prämierten Erfindungen eröffnen neue Konzepte zur Therapie von HIV-Infektionen, zur Behandlung von Netzhauterkrankungen und zeigen auf, wie Proteine die Herstellung von LEDs effizienter und umweltfreundlicher machen. Die…

AbbVie: ITTM and AbbVie to collaborate on Disease Map for Alzheimer’s

On April 7, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für AbbVie: ITTM and AbbVie to collaborate on Disease Map for Alzheimer’s

Information Technology for Translational Medicine, S.A. (ITTM S.A.) announced today that it has signed a two-year agreement with AbbVie Germany to develop and build a comprehensive and interactive up-to-date knowledge map for Alzheimer’s Disease. The disease map will be built using MINERVA, a platform for visualization and curation of molecular…

AbbVie: PLUS – Die Gesundheitsinitiative Hepatitis C in Ludwigshafen

On April 7, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für AbbVie: PLUS – Die Gesundheitsinitiative Hepatitis C in Ludwigshafen

In Ludwigshafen startet offiziell „PLUS – Die Gesundheitsinitiative Hepatitis C“ mit einer prominent besetzten Auftaktveranstaltung. Das Ziel: Die gesundheitliche und psychosoziale Lebens- und Versorgungssituation von Drogenkonsumenten, Substituierten und Abstinenzwilligen zu verbessern. Langfristig wollen die Partner so auch die Häufigkeit der Infektionen mit dem Hepatitis-C-Virus in Ludwigshafen reduzieren. Initiatoren sind AbbVie,…

EMBL/DKFZ: Blood stem cell differentiation is continuous

On April 7, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für EMBL/DKFZ: Blood stem cell differentiation is continuous

Study by EMBL and DKFZ researchers means origins of myeloid leukaemias may need rethinking. Every day, your body has to generate up to one trillion new blood cells, more if you suffer from an infection or severe bleeding. Ultimately, all of these cells derive from the adult haematopoietic stem cells…

Roche: Roche launches cobas Liat PCR System with four assays into CE-markets

On April 5, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Roche: Roche launches cobas Liat PCR System with four assays into CE-markets

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the CE-IVD launch of the cobas® Liat® PCR System with four assays including first 20 minute real-time PCR nucleic acid test to detect Clostridium difficile (C. diff). Countries accepting CE mark are the first to receive access to the cobas® Cdiff test,…

DKFZ: Antibody is effective against radiation-induced pulmonary fibrosis

On April 5, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für DKFZ: Antibody is effective against radiation-induced pulmonary fibrosis

Radiation therapy of the lungs often leads to irreversible connective-tissue changes that cause functional impairments in the pulmonary tissue. Scientists from the German Cancer Research Center (DKFZ) have now been able to prevent, and even reverse this process in mice using an antibody. Radiation therapy is part of the treatment…

DKFZ: A biomarker for cancer of the oropharynx

On April 5, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für DKFZ: A biomarker for cancer of the oropharynx

A growing number of cases of oropharyngeal cancer are considered to be a consequence of infection with human papillomaviruses (HPV). Scientists at the German Cancer Research Center (DKFZ) have now revealed that a single blood sample test for specific antibodies can identify persons who are at a high risk of…

EMBL: Ageing: cell coordination breakdown

On April 5, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für EMBL: Ageing: cell coordination breakdown

Researchers use single-cell sequencing to understand how cells age Researchers from the European Bioinformatics Institute (EMBL-EBI), University of Cambridge, the Wellcome Trust Sanger Institute and the Cancer Research UK–Cambridge Institute (CRUK-CI) have shed light on a long-standing debate about ageing and why the immune system weakens with age. Their findings,…

Boehringer Ingelheim: Novozymes and Boehringer Ingelheim announce Strategic Collaboration in Probiotics for Poultry Hatcheries

On April 3, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Boehringer Ingelheim: Novozymes and Boehringer Ingelheim announce Strategic Collaboration in Probiotics for Poultry Hatcheries

Ingelheim, Germany & Copenhagen, Denmark – 30 March 2017 – Boehringer Ingelheim Animal Health and Novozymes today announced a strategic collaboration to develop and commercialize probiotics for global poultry production. The parties will focus on developing products for hatcheries, the facilities where eggs are hatched before the chickens move to grow-out…

Heidelberg University: Motor Neurons Tell Blood Vessels Where To Go

On März 31, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Heidelberg University: Motor Neurons Tell Blood Vessels Where To Go

Heidelberg Neuroscientists have identified a critical regulator for blood vessel growth in the developing embryonic spinal cord. The research group under the direction of Dr Carmen Ruiz de Almodóvar of the Heidelberg University Biochemistry Center discovered that special nerve cells known as motor neurons control this process. This new insight…

Heidelberg University: New Class of Scientific Fellows Appointed to the Marsilius-Kolleg with interdisciplinary research issues and projects

On März 31, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Heidelberg University: New Class of Scientific Fellows Appointed to the Marsilius-Kolleg with interdisciplinary research issues and projects

A new class of fellows has been appointed to the Marsilius Kolleg, Heidelberg University’s interdisciplinary Centre for Advanced Study. From April 2017 to March 2018, fourteen Heidelberg scientists and scholars will engage with interdisciplinary research issues and participate in discussions at the Kolleg. At their regular sessions, the fellows are…